In a prospective study, a combined detection of NPY methylation along with tumor‐specific mutations in ctDNA could give similar results to radiographic evaluation, showing that this combined liquid biopsy approach can be used for the follow‐up of mCRC patients during treatment [79]. Here, NPY is linked to neoplasm.